Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.9K Sell
1,074
-29,680
-97% -$2.39M ﹤0.01% 230
2026
Q1
$2.43M Sell
30,754
-6,482
-17% -$485K 0.08% 130
2025
Q4
$2.94M Buy
37,236
+6,624
+22% +$524K 0.08% 124
2025
Q3
$2.47M Buy
30,612
+932
+3% +$73.3K 0.07% 112
2025
Q2
$2.4M Buy
29,680
+1,666
+6% +$129K 0.08% 121
2025
Q1
$2.22M Buy
28,014
+6,734
+32% +$560K 0.09% 117
2024
Q4
$1.72M Buy
21,280
+21,213
+31,661% +$1.77M 0.01% 125
2024
Q3
$5.53K Hold
67
﹤0.01% 330
2024
Q2
$4.7K Sell
67
-9,610
-99% -$686K ﹤0.01% 309
2024
Q1
$714K Buy
+9,677
New +$675K 0.03% 187

Other funds holding MET

BNP Paribas's MET Position: Q2 2026 in Review

BNP Paribas reduced its MetLife (MET) stake by 97% in Q2 2026, selling an estimated $2.39M and leaving 1,074 shares worth $91.9K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

BNP Paribas first reported a position in MET in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.94M in Q4 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • BNP Paribas held 1,074 shares of MetLife worth $91.9K as of Q2 2026.
  • BNP Paribas sold 29,680 MetLife shares in Q2 2026, an estimated $2.39M.
  • MetLife made up ﹤0.01% of BNP Paribas's portfolio in Q2 2026, its #230 holding.
  • BNP Paribas first reported a position in MetLife in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's MetLife position peaked at $2.94M in Q4 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.